The National Central Cancer Registry of China (NCCR) was the only available source of cancer monitoring in China, even though only about 70% of cancer registration sites were qualified by now. In this study, based on a national large prospective cohort-the China Kadoorie Biobank (CKB), we aimed to provide additional cancer statistics and compare the difference of cancer burden between urban and rural areas of China. A total of 497,693 cancer-free participants aged 35-74 years were recruited and successfully followed up from 2004 to 2013 in 5 urban and 5 rural areas across China. Except for traditional registration systems, the national health insurance system and active follow-up were used to determine new cancer incidents and related death...
Abstract Background The long‐term trend in cancer death in a rapidly developing country provides inf...
Objective: To compare the validity of mortality data from available sources in China. Materials, Me...
Summary: Background: From 2003 to 2005, standardised 5-year cancer survival in China was much lower...
The National Central Cancer Registry of China (NCCR) was the only available source of cancer monitor...
Abstract Background The National Central Cancer Registry (NCCR) collected population-based cancer re...
Abstract Introduction Population-based cancer registration data are collected by the National Centra...
In 2012, the National Central Cancer Registry (NCCR) of China collected cancer registration informat...
Background: Population-based cancer registry collects the data on cancer incidence and mortality dea...
Objective: The aim of this study was to investigate the cancer incidence and mortality in Huai’an ar...
After several decades of development, the socialist market economy of China is now the world’s secon...
Objective The substantial differences in socioeconomic and lifestyle exposures between urban and rur...
Limited population-based cancer registry data available in China until now has hampered efforts to i...
Abstract Background Cancer is one of the leading causes of death and a main economic burden in China...
Introduction: Disparities in the incidence, mortality, and survival of cancer types between urban an...
Introduction: Disparities in the incidence, mortality, and survival of cancer types between urban an...
Abstract Background The long‐term trend in cancer death in a rapidly developing country provides inf...
Objective: To compare the validity of mortality data from available sources in China. Materials, Me...
Summary: Background: From 2003 to 2005, standardised 5-year cancer survival in China was much lower...
The National Central Cancer Registry of China (NCCR) was the only available source of cancer monitor...
Abstract Background The National Central Cancer Registry (NCCR) collected population-based cancer re...
Abstract Introduction Population-based cancer registration data are collected by the National Centra...
In 2012, the National Central Cancer Registry (NCCR) of China collected cancer registration informat...
Background: Population-based cancer registry collects the data on cancer incidence and mortality dea...
Objective: The aim of this study was to investigate the cancer incidence and mortality in Huai’an ar...
After several decades of development, the socialist market economy of China is now the world’s secon...
Objective The substantial differences in socioeconomic and lifestyle exposures between urban and rur...
Limited population-based cancer registry data available in China until now has hampered efforts to i...
Abstract Background Cancer is one of the leading causes of death and a main economic burden in China...
Introduction: Disparities in the incidence, mortality, and survival of cancer types between urban an...
Introduction: Disparities in the incidence, mortality, and survival of cancer types between urban an...
Abstract Background The long‐term trend in cancer death in a rapidly developing country provides inf...
Objective: To compare the validity of mortality data from available sources in China. Materials, Me...
Summary: Background: From 2003 to 2005, standardised 5-year cancer survival in China was much lower...